China (Mainland)
Diamondsupplier 
Factory supply Timolol Maleate CAS 26921-17-5 CAS NO.26921-17-5
- FOB Price: USD: 500.00-500.00 /Metric Ton Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,MoneyGram,Other
- Available Specifications:
USP(500-1000)Metric Ton
- Product Details
Keywords
- Timolol Maleate
- 26921-17-5
- Timolol
Quick Details
- ProName: Factory supply Timolol Maleate CAS 26...
- CasNo: 26921-17-5
- Molecular Formula: C17H28N4O7S
- Appearance: white powder
- Application: eye drugs
- DeliveryTime: in 7 days
- PackAge: 1kg/tin
- Port: Shanghai/Beijing/Tianjin
- ProductionCapacity: 100 Metric Ton/Year
- Purity: 99%
- Storage: room temperature
- Transportation: regular transportation
- LimitNum: 1 Kilogram
Superiority
Why is SINOWAY:
1) Specialized in pharmaceutical and healthcare industrial for 34 years.
2) ISO 9001:2015 & SGS audited supplier .
3) Accept various payment terms : T.T 30-60 days.
4) We have warehouse in USA with quickly shipment .
5) We can do different terms of FOB ,CIF/CIP ,DDP ...
Our Advantange of Timolol Maleate:
Best Quality and Competitive price
Details
The Basic information of Timolol Maleate CAS 26921-17-5
| Name | Timolol Maleate |
| CAS | 26921-17-5 |
| MF | C17H28N4O7S |
The COA of Timolol Maleate CAS 26921-17-5
The Use of Timolol Maleate CAS 26921-17-5
Timolol maleate is a new potent β -receptor blocker, which can block β1 and β2 receptors with 8 times the intensity of propranolol. It has no membrane stability, no endogenous sympathetic-like activity, no direct inhibition of heart, and has a significant effect on reducing intraocular pressure.It is used to treat hypertension, angina pectoris Chemicalbook, tachycardia and glaucoma.It has a good effect on mild and moderate hypertension, without obvious adverse reactions, and can be combined with diuretics.Long-term medication can reduce the incidence of reinfarction and mortality in patients with myocardial infarction.It has a good effect on glaucoma, especially primary and open Angle glaucoma, which is better than traditional iOP drugs.
